Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use venlafaxine hydrochloride extended-release capsules safely and effectively. See full prescribing information for venlafaxine hydrochloride extended-release capsules. VENLAFAXINE hydrochloride extended-release capsules, USP for oral useInitial U.S. Approval: 1997
Medication labelWhy this: Advisory · dailymed-prescription
Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of major depressive disorder (MDD). Efficacy was established in three short-term (4, 8, and 12 weeks) and two long-term, maintenance trials. Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of Social Anxiety Disorder (SAD), also known as social phobia. Efficacy was established in four 12-week and one 26-week, placebo-controlled trials. Venlafaxine hydrochloride extended-release capsules, USP are indicated for the treatment of Panic Disorder (PD), with or without agoraphobia. Efficacy was established in two 12-week placebo-controlled trials.
- generic_name
- venlafaxine hydrochloride
- product_names
- venlafaxine hydrochloride
- ndc
- 53217-194, 68382-036, 53217-194-01, 53217-194-30, 53217-194-60, 53217-194-90, 53217-194-93, 53217-194-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en